Isopaque one-step gradient and the whole mononuclear population was collected and used. The cells were exposed to EBV-B95-8 for 1 h, whereafter they were cultured in RPMI medium containing 10% fetal calf serum (FCS) under standard tissue culture conditions. Bone marrows from 13 different fetuses were infected, and in all cases EBVpositive cell lines were obtained. Uninfected control cultures did not give rise to any cell lines. One line was lost, so we present data on 12 lines, one subclone, and 2 lines from fetal liver. The cell lines were considered as established after 3-4 wk in culture, when they were given a serial number and designated as follows: Fe, fetal; BM, bone marrow derived; Li, liver derived; E, EBV transformed; 95, derived from B95-8 strain (9) of EBV; and Sto, cell lines established at the Department of Tumor Biology, Karolinska Institutet.
Immunofluorescence Assays. Presence of surface or intracellular Ig was detected with fluorescein isothiocyanate (FITC)-conjugated rabbit anti-human heavy or light chainspecific sera (Dakopatts, Copenhagen) on 5 x 105 live cells (for sIg) or 104 fixed cells on cytosmears (intracellular Ig). At least 200 cells were examined in a Leitz fluorescence microscope, and each cell line was tested in three or more separate experiments. Reactivity with the monoclonal antibodies was detected with a fluorescinated second rabbit antibody (Litton Bionetics Inc., Kensington, MD), directed against mouse IgM (for LB-1 and BB-1) or mouse Ig (for B2). The second antibody was diluted 1:10 with balanced salt solution (BSS) in 10% EBV-negative sera.
Assay for Fc and C3 Receptors. Presence of Fc and C3 receptors was assayed in parallel with standard rosetting techniques using ox erythrocytes (I 0).
Cloning in Soft Agarose. The cloning frequency was determined by plating the cells in soft agarose as described previously (11) .
Results and Discussion
In this paper we describe the establishment and characterization of 12 lymphoblastoid cell lines from fetal bone marrow and 2 from fetal liver, by EBV transformation. The easily identifiable events of the primary infection, appearance of EBNA and induction of DNA synthesis, showed a pattern similar to that in cord blood and adult B lymphocytes. In these experiments we have used the whole heterogenous population of bone marrow cells as targets for the infection. The selection of immortalized cells is thus based on the distribution of EBV receptors and sensitivity to virus transformation among these cells.
There is no information available to allow preselection of stem cells or pre-B cells in the human bone marrow, and nothing is yet known about the EBV receptor distribution on such cells. The fresh fetal bone marrow cells that were infected consisted of immature hematopoeitic cells, out of which 8-17% could be identified as B cells by their sIgM expression. Thus, most of the established cell lines (I 0/15) carried sIgM with variable levels of sIgD and equal proportions of kappa-and lambda-expressing cells (Table I ). Since no attempt was made to clone the EBV-infected cells, except in one case (FeBM-14-E95-Sto), the lines are polyclonal as expected. Five cell lines derived from the younger fetuses (_ 16 wk) expressed no sIg at all, but all belonged to the B cell lineage, as they synthesized intracellular Ig, either # chain alone, or # heavy chain and K or 2~ light chain, a pattern characteristic for pre-B cells ( Fig. 1 and Table I ).
These cell lines clearly represent at least two major stages in B cell differentiation; the sIg-pre-B cell and the sIgM+/IgD + fetal B lymphocyte. Among the cell lines representing the pre-B cell stage, one of them (FeBM-11-E95-Sto) may be of early pre-B type, since it expresses only ~ chain and no light chain in its cytoplasm. As can be seen in Table I , the frequency of positive cells varies between the lines. There was always a large proportion of cells scored as Ig-, as j u d g e d f r o m b o t h i n t r a c e l l u l a r a n d s u r f a c e I g s t a i n i n g . It is u n l i k e l y , b u t still p o s s i b l e , in t h e s e p o l y c l o n a l l i n e s t h a t s e v e r a l " c l o n e s " f r o z e n a t d i f f e r e n t levels o f B d i f f e r e n t i a t i o n a r e g r o w i n g i n d e p e n d e n t l y o f e a c h o t h e r . O n e a r g u m e n t a g a i n s t t h i s is t h e fact t h a t t h e o n e c l o n e a n a l y z e d ( F e B M -1 4 -E 9 5 -S t o c l o n e 1) Table I . * Mean percent positive cells of two to three experiments on each cell line. ND, not done. t As controls for optimal rosetting conditions, K562 and Daudi were used in each experiment; they were 100% Fc or C3 receptor positive, respectively. I As controls in each cloning experiment, the Burkitt line, Raji, was used, showing a cloning frequency of 62%; a randomly chosen adult B-LCL was also included, with a mean cloning efficiency of 3.5%.
also contained negative cells. Thus, there may be a variation of Ig expression within the individual clones, whereas 100% of the cells in all lines were positive for the HLA-associated beta-2 microglobulin (data not shown). In vitro infection of adult peripheral blood lymphocyte (PBL)-derived B lymphocytes with EBV usually results in an increase in Ig synthesis and in some cells maturing into Ig-secreting plasma cells (4) . It is possible that the pre-B cells in the human fetus fail to undergo any differentiation upon EBV infection due to their immunoincompetence. In the mouse system, information on B cell antigens confined to stages of differentiation is being obtained with the use of monoclonal antibodies (12) . Recently some monoclonal antibodies that recognize human B cell antigens have become available; further characterization of our EBV-transformed fetal lines has involved the use of three such monoclonal antibodies (Table II) . LB-1 has been described by Youkochi and co-workers (13) as detecting a lymphoblastoid antigen present on LCL of B cell origin and mitogen-activated lymphocytes, but not on a pre-B leukemia (NALM-6), Burkitt lymphoma-derived cell lines, or plasma cell-like myelomas. BB-1 shows a similar pattern of reactivity except that it detects a B lymphoblastoid antigen on mitogenactivated sIg + cells and also reacts with Burkitt lines. The antigen recognized by the other monoclonal, B2, is present on both normal resting B cells and malignant early sIg + B cells, but is lost during maturation and is absent on plasma cell-like malignancies (14) . Our data suggest that the two antigens detected by LB-1 and BB-1 are also induced on the sIg-pre-B cells by EBV transformation (Table II) lines tested were positive for both these antigens whether they belonged to the slg + or slg-group (Table Ii) . The B2 antigen showed a much weaker staining and fewer positive cells overall but no obvious difference between the more immature lines and the slg + cell lines. The presence of Fc receptors varied among the cell lines while the C3 receptors that were tested in parallel were strongly expressed on all cell lines (Table II) . Although the presence or absence of Fc receptors cannot be used to define a certain maturation stage, it is interesting to note that our sIg-cell lines all have very low amounts of Fc receptor-positive cells. This is in contrast to the pre-B cell lines established from the patients with X-linked agammaglobulinemia (X-LA) described by Fu et al. (15) , which were the most immature lines, of possibly precursor type, and which had a high percentage of Fc receptor-positive cells. Some EBV-associated Burkitt lymphoma tumor lines are usually thought to represent an immature B cell since they lack slgD and do not secrete Ig (16) . These are highly malignant monoclonal tumors with a high cloning efficiency in soft agar. In vitro transformed peripheral B lymphocytes have at least a 10-fold lower cloning efficiency (17) . To find out whether these in vitro transformed fetal lines would be more "Burkittqike" because of their immaturity, we also tested their cloning capacity in soft agar (Table II) . We found no difference between the two groups of fetal cell lines, and they did not differ in their cloning capacity from the more mature conventional adult B-LCL.
In Fig. 2 we have summarized some of the current information on B cell development in man, together with the information on EBV susceptibility gained from our study. It is a probable assumption that the EBV-positive lines (Josh 7 and Josh :3) from a patient with X-LA that lack both intracellular heavy and light chain (15) , represent a precursor B cell that is also present in healthy individuals. The next identifiable step in human B cell development would be synthesis of only intracellular ~ chain, represented by the lines Josh 4 and FeBM-11-E95-Sto.
The establishment of these FeBM lines supports the suggestion by Fu et al. (15) that normal pre B cells also can be transformed by EBV.
Before the pre-B cell matures into a surface IgM + B lymphocyte, both heavy and light chains appear in the cytoplasm. Fc and C3 receptors, although not unique for the B cell lineage, are indicated in Fig. 2 as they appear or disappear during B cell ontogeny. In addition to previous information concerning the distribution of antigens detected by monoclonal antibodies and the presence of the EBV receptor, we have added the new information that these are also present on pre-B cell lines. EBV-transformed fetal cell lines could serve as the normal counterpart to the more often studied pre-B cell characteristics on cells from malignancies that affect the B cell lineage. With regard to defining both certain cell surface markers and differentiation steps, the transformed normal pre-B cells are advantageous since many of these malignant cells can not be cultured in vitro, a prerequisite for such studies. In conclusion, this study shows that fetal bone marrow and liver contain cells that can serve as targets for EBV. The morphology, EBNA expression, growth pattern, and cloning efficiency in soft agar were similar to that of normal adult B-LCL. Both sIg ÷ and sIg-B cells have the EBV receptor, indicating that the transformed cell lines represent normal B cell maturation stages.
Summary
In vitro infection of human B lymphocytes with Epstein-Barr virus (EBV) results in establishment of B lymphoblastoid cell lines that reflect normal B cell phenotypes. In this study we have investigated whether immature B cells from fetal bone marrow and liver can serve as targets for EBV. The fetal bone marrow cells were readily transformed by EBV. Among the resulting cell lines, five were surface Ig (sIg)-negative. Three B cell-associated antigens defined by monoclonal antibodies were expressed to the same extent on the fetal cell lines, whether they belonged to the sIg-or sIg + group. The various differentiation stages that these cell lines may represent are discussed.
